Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up

American Journal of Psychiatry

Volumn 160, Issue 7, 2003, Pages 1252-1262

  Altshuler, Lori ^a,b   Suppes, Trisha ^a   Black, David ^a   Nolen, Willem A ^a   Keck Jr , Paul E ^a   Frye, Mark A ^a   McElroy, Susan ^a   Kupka, Ralph ^a   Grunze, Heinz ^a   Walden, Jörg ^a   Leverich, Gabrielle ^a   Denicoff, Kirk ^a   Luckenbaugh, David ^a   Post, Robert ^a  

^a Stanley Bipolar Treatment Network   (Falkland Islands (Malvinas))

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTICONVULSIVE AGENT;

ADULT; ARTICLE; BIPOLAR DEPRESSION; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; RISK ASSESSMENT; ACUTE DISEASE; BIPOLAR DISORDER; COMPARATIVE STUDY; DEPRESSION; DRUG ADMINISTRATION; DRUG COMBINATION; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; REGRESSION ANALYSIS; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ACUTE DISEASE; ADULT; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; RECURRENCE; REGRESSION ANALYSIS; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 0041977105     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.7.1252     Document Type: Article

References (61)

1. Frances A, Kahn D, Carpenter S, Docherty J, Donovan S: The expert consensus guidelines for treating depression in bipolar disorder. J Clin Psychiatry 1998; 59(suppl 4): S73-S79
2. Yatham L, Kusumakar V, Parikh S, Haslam D, Matte R, Sharma V, Kennedy S: Bipolar depression: treatment options. Can J Psychiatry 1997; 42(suppl 2): S87-S91
3. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP: The Expert Consensus Guidelines Series: Medication Treatment of Bipolar Disorder. New York, McGraw-Hill, April 2000, pp 1-102
4. Prien RF, Klett CJ, Caffey EM: Lithium carbonate and imipramine in prevention of affective episodes. Arch Gen Psychiatry 1973; 29:420-425
5. Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB, Johnson WE: Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Arch Gen Psychiatry 1984; 41:1096-1104
6. Altshuler L, Kiriakos L, Calcagno J, Goodman R, Gitlin M, Frye M, Mintz J: The impact of antidepressant discontinuation versus antidepressant continuation on one-year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry 2001; 62:612-616
7. Leverich GS, Nolen WA, Rush AJ, McElroy SL, Keck PE Jr, Denicoff KD, Suppes T, Altshuler LL, Kupka R, Kramlinger KG, Post RM: The Stanley Foundation Bipolar Treatment Outcome Network, I: longitudinal methodology. J Affect Disord 2001; 67:33-44
8. Post RM, Altshuler LL, Frye MA, Suppes T, Rush AJ, Keck PE Jr, McElroy SL, Denicoff KD, Leverich GS, Kupka R, Nolen WA: Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disord 2001; 3:259-265
9. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-IV (SCID). New York, New York State Psychiatric Institute, Biometrics Research, 1995
10. Spearing M, Post R, Leverich G, Brandt D, Nolen W: Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI for bipolar disorder. Psychiatry Res 1997; 73:159-171
11. Quitkin FM, Kane J, Rifkin A, Lorenzi-Ramos JR, Nayak DV: Prophylactic lithium carbonate with and without imipramine for bipolar I patients. Arch Gen Psychiatry 1981; 38:902-907
12. Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A: Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch Gen Psychiatry 1982; 39:1065-1069
13. Johnstone E, Owens D, Lambert M, Crow T, Frith C, Done D: Combination tricyclic antidepressant and lithium maintenance medication in unipolar and bipolar depressed patients. J Affect Disord 1990; 20:225-233
14. Wehr TA, Goodwin FK: Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979; 36:555-559
15. Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L: Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol 1980; 13:156-167
16. Wehr TA, Goodwin SK: Do antidepressants cause mania? Psychopharmacol Bull 1987; 23:61-65
17. Wehr T, Goodwin F: Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144:1403-1411
18. Peet M: Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994; 164:549-550
19. Lerer B, Birmacr B, Ebstein RP, Belmaker RH: 48-hour depressive cycling induced by antidepressants. Br J Psychiatry 1980; 137:181-185
20. Wehr TA, Sack DA, Rosenthal NE, Cowdry RW: Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988; 145:179-184
21. Tondo L, Laddomada P, Serra G, Minnai G, Kukopulos A: Rapid cyclers and antidepressants. Int Pharmacopsychiatry 1981; 16: 119-123
22. Kukopulos A, Caliari B, Tundo A, Minnai G, Florrs G, Reginaldi D, Tondo I: Rapid cyclers, temperament and antidepressants. Compr Psychiatry 1983; 24:249-258
23. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L: Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152:1130-1138
24. Shapiro DR, Quitkin FM, Fleiss JL: Response to maintenance therapy in bipolar illness: effect of index episode. Arch Gen Psychiatry 1989; 46:401-405
25. Stoll AL, Mayer PV, Kolbrener M, Goldstein E, Suplit B, Lucier J, Cohen BM, Tohen M: Antidepressant-associated mania: a controlled comparison with spontaneous mania. Am J Psychiatry 1994; 151:1642-1645
26. Nasrallah HA, Lyskowski J, Schroeder D: TCA-induced mania: differences between switchers and nonswitchers. Biol Psychiatry 1982; 17:271-274
27. Wehr TA, Goodwin SK: Tricyclics modulate frequency of mood cycles. Chronobiologia 1979; 6:377-385
28. Baldessarini RJ, Tondo L, Viguera AC: Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disord 1999; 1:17-24
29. Faedda GL, Baldessarini RJ, Suppes T, Tondo L, Becker I, Lipschitz D: Pediatric-onset bipolar disorder: a neglected clinical and public health problem. Harv Rev Psychiatry 1995; 3:171-195
30. Suppes T, Baldessarini RJ, Faedda GL, Tohen M: Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991; 48:1082-1088
31. Koukopoulos A, Reginaldi D, Minnai G, Serra G, Pani L, Johnson FN: The long term prophylaxis of affective disorders, in Depression and Mania: From Neurobiology to Treatment, vol 49. Edited by Gessa G, Fratta W, Pani L, Serra G. New York, Raven Press, 1995, pp 127-147
32. Viguera AC, Baldessarini RJ, Friedberg J: Discontinuing antidepressant treatment in major depression. Harv Rev Psychiatry 1998; 5:293-306
33. Shriver AE, Sachs GS, Baldassano CF: Mania and hypomania following antidepressant discontinuation, in 1998 Annual Meeting New Research Program and Abstracts. Washington, DC, American Psychiatric Association, 1998, number 161, p 111
34. Goldstein TR, Frye MA, Denicoff KD, Smith-Jackson E, Leverich GS, Bryan AL, Ali SO, Post RM: Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications in bipolar disorder. J Clin Psychiatry 1999; 60:563-567
35. Mirin SM, Schatzberg AF, Creasey DE: Hypomania and mania after withdrawal of tricyclic antidepressants. Am J Psychiatry 1981; 138:87-89
36. Dilsaver SC, Greden JF: Antidepressant withdrawal-induced activation (hypomania and mania): mechanism and theoretical significance. Brain Res Brain Res Rev 1984; 7:29-48
37. Zajecka J, Tracy KA, Mitchell S: Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. J Clin Psychiatry 1997; 58:291-297
38. Calabrese JR, Rapport DJ, Kimmel SE, Shelton MD: Controlled trials in bipolar I depression: focus on switch rates and efficacy. Eur Psychopharmacol 1999; 9(suppl 4): S109-S112
39. Rouillon F, Lejoyeux M, Filteau MJ: Unwanted effects of long term treatment, in Long Term Treatment of Depression. Edited by Montgomery SA, Rouillon FA. New York, John Wiley & Sons, 1992, pp. 81-111
40. Nolen WA, Bloemkolk D: Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm. Neuropsychobiology 2000; 42 (suppl 1):11-17
41. Ghaemi SN, Lenox MS, Baldessarini RJ: Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry 2001; 62:565-569
42. Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, Oakes R, Pitts CD: Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001; 158:906-912
43. Barak Y, Kimhi R, Weizman R: Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients? Int Clin Psychopharmacol 2000; 15:53-56
44. Silverstone T: Moclobemide vs imipramine in bipolar depression: a multicentre double-blind clinical trial. Acta Psychiatr Scand 2001; 104:104-109
45. Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M: Antidepressant- induced mania in bipolar patients: identification of risk factors. J Clin Psychiatry 2001; 62:249-255
46. Goren JL, Levin GM: Mania with bupropion: a dose-related phenomenon? Ann Pharmacother 2000; 34:619-621
47. Joffe RT, MacQueen GM, Marriott M, Robb J, Begin H, Young LT: Induction of mania and cycle acceleration in bipolar disorder: effect of different classes of antidepressant. Acta Psychiatr Scand 2002; 105:427-430
48. Himmelhoch JM, Thase ME, Mallinger AG, Houck P: Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991; 148:910-916
49. Angst J: Switch from depression to mania - a record study of decades between 1920-1982. Psychopathology 1985; 18:140-154
50. Boerlin HL, Gitlin MJ, Zoellner LA, Hammen CL: Bipolar depression and antidepressant-induced mania: a naturalistic study. J Clin Psychiatry 1998; 59:374-379
51. Lewis JL, Winokur G: The induction of mania: a natural history study with controls. Arch Gen Psychiatry 1982; 39:303-306
52. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (Lamictal 602 Study Group): A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999; 60:79-88
53. Sachs GS, Lafer B, Stoll AL, Banov M, Thibault AB, Tohen M, Rosenbaum JF: A double-blind trial of bupropion vs desipramine for bipolar depression. J Clin Psychiatry 1994; 55: 391-393
54. Cohn JB, Collins G, Ashbrook E, Wernicke JF: A comparison of fluoxetine, imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989; 4:313-322
55. Sachs GS, Koslow CL, Ghaemi SN: The treatment of bipolar depression. Bipolar Disord 2000; 2:256-260
56. Bottlender R, Rudolf D, Strauss A, Möller HJ: Mood-stabilizers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients. J Affect Disord 2001; 63:79-83
57. Jann MW, Bitar AH, Rao A: Lithium prophylaxis of tricyclic- antidepressant-induced mania in bipolar patients. Am J Psychiatry 1982; 139:683-684
58. Möller HJ, Grunze H: Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur Arch Psychiatry Clin Neurosci 2000; 250:57-58
59. American Psychiatric Association: Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000; 157(April suppl)
60. Kupfer DJ. Long-term treatment of depression. J Clin Psychiatry 1991; 52:(suppl 5):28-34
61. Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Siotis I: Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry 2000; 157:124-126